Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir Intensification for Persistent HBV in HIV-HBV Coinfection
NCT00662545Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Apr 2008
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in hepatitis B (HBV) comparing Entecavir Intensification with Standard of Care (2 arms). Primary endpoint: Mean log10 reduction of Hepatitis B Virus (HBV) DNA at 24 weeks. Started Apr 2008; status: completed.
02
Drugs
entecavir
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00662545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00662545.